Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment

Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment

Submitted by admin on September 18, 2018 - 10:00am
Source: 
Stat
News Tags: 
Viking Therapeutics
NASH
non-alcoholic fatty liver disease
VK2809
clinical trials
Headline: 
Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment
snippet: 

An experimental pill from Viking Therapeutics (VKTX) reduced liver fat in patients with early signs of fatty liver disease, according to results from a mid-stage clinical trial announced Tuesday.

Do Not Allow Advertisers to Use My Personal information